Auxly Cannabis Group Stock EBITDA
| XLY Stock | CAD 0.04 0 7.14% |
Auxly Cannabis Group fundamentals help investors to digest information that contributes to Auxly Cannabis' financial success or failures. It also enables traders to predict the movement of Auxly Stock. The fundamental analysis module provides a way to measure Auxly Cannabis' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Auxly Cannabis stock.
| Last Reported | Projected for Next Year | ||
| EBITDA | -30.9 M | -29.4 M |
Auxly | EBITDA |
Auxly Cannabis Group Company EBITDA Analysis
Auxly Cannabis' EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current Auxly Cannabis EBITDA | (30.95 M) |
Most of Auxly Cannabis' fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Auxly Cannabis Group is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Auxly EBITDA Driver Correlations
Understanding the fundamental principles of building solid financial models for Auxly Cannabis is extremely important. It helps to project a fair market value of Auxly Stock properly, considering its historical fundamentals such as EBITDA. Since Auxly Cannabis' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Auxly Cannabis' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Auxly Cannabis' interrelated accounts and indicators.
Click cells to compare fundamentals
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
| Competition |
Auxly Ebitda
According to the company disclosure, Auxly Cannabis Group reported earnings before interest,tax, depreciation and amortization of (30.95 Million). This is 103.53% lower than that of the Pharmaceuticals sector and significantly lower than that of the Health Care industry. The ebitda for all Canada stocks is 100.79% higher than that of the company.
Auxly EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Auxly Cannabis' direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Auxly Cannabis could also be used in its relative valuation, which is a method of valuing Auxly Cannabis by comparing valuation metrics of similar companies.Auxly Cannabis is currently under evaluation in ebitda category among its peers.
Auxly Cannabis Current Valuation Drivers
We derive many important indicators used in calculating different scores of Auxly Cannabis from analyzing Auxly Cannabis' financial statements. These drivers represent accounts that assess Auxly Cannabis' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Auxly Cannabis' important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 322.1M | 161.0M | 144.9M | 17.8M | 9.9M | 9.4M | |
| Enterprise Value | 377.7M | 264.5M | 320.3M | 196.8M | 153.3M | 80.5M |
Auxly Fundamentals
| Return On Equity | -0.52 | ||||
| Return On Asset | -0.0309 | ||||
| Profit Margin | (0.41) % | ||||
| Operating Margin | 0.17 % | ||||
| Current Valuation | 96.4 M | ||||
| Shares Outstanding | 1.25 B | ||||
| Shares Owned By Insiders | 21.73 % | ||||
| Shares Owned By Institutions | 0.24 % | ||||
| Number Of Shares Shorted | 348.01 K | ||||
| Price To Book | 0.39 X | ||||
| Price To Sales | 0.41 X | ||||
| Revenue | 101.08 M | ||||
| Gross Profit | 19.29 M | ||||
| EBITDA | (30.95 M) | ||||
| Net Income | (44.51 M) | ||||
| Cash And Equivalents | 14.64 M | ||||
| Cash Per Share | 0.02 X | ||||
| Total Debt | 159.04 M | ||||
| Debt To Equity | 1.20 % | ||||
| Current Ratio | 2.58 X | ||||
| Book Value Per Share | 0.05 X | ||||
| Cash Flow From Operations | 8.21 M | ||||
| Short Ratio | 0.88 X | ||||
| Earnings Per Share | (0.07) X | ||||
| Target Price | 0.02 | ||||
| Number Of Employees | 369 | ||||
| Beta | 1.22 | ||||
| Market Capitalization | 44.93 M | ||||
| Total Asset | 261.9 M | ||||
| Retained Earnings | (483.27 M) | ||||
| Working Capital | (38.98 M) | ||||
| Net Asset | 261.9 M |
About Auxly Cannabis Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Auxly Cannabis Group's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Auxly Cannabis using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Auxly Cannabis Group based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Other Information on Investing in Auxly Stock
Auxly Cannabis financial ratios help investors to determine whether Auxly Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Auxly with respect to the benefits of owning Auxly Cannabis security.